Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation
Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2879-2898.e24
Open Access | Times Cited: 311

Showing 51-75 of 311 citing articles:

Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections
Gina A. Suh, Tristan Ferry, Matthew P. Abdel
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S407-S415
Open Access | Times Cited: 22
The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice
Zhirui Cao, Dejun Fan, Yang Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Protective effect of synbiotic combination of Lactobacillus plantarum SC-5 and olive oil extract tyrosol in a murine model of ulcerative colitis
Fazheng Yu, Xueyu Hu, Honglin Ren, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Endogenous ethanol production in health and disease
Abraham S. Meijnikman, Max Nieuwdorp, Bernd Schnabl
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 556-571
Closed Access | Times Cited: 14
Metabolic network of the gut microbiota in inflammatory bowel disease
Kohei Sugihara, Nobuhiko Kamada
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 13
Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Jiaying Zheng, Qianru Sun, Mengjing Zhang, et al.
Nature Medicine (2024)
Open Access | Times Cited: 12
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 11
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Wang Xiu, Jianhua Peng, Pei-Pei Cai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117302-117302
Open Access | Times Cited: 11
The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever
Gregg J. Silverman, Doua F. Azzouz, Nicolas Gisch, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 3, pp. 143-157
Closed Access | Times Cited: 10
5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner
Qing Meng, Jianshuang Guo, Ke Lv, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2153-2176
Open Access | Times Cited: 9
Safety and efficacy of phage application in bacterial decolonisation: a systematic review
Qingqing Fang, Xin Yin, Yanling He, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 5, pp. e489-e499
Open Access | Times Cited: 9
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
Serena Porcari, William G. Fusco, Igor Spivak, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 5, pp. 460-475
Closed Access | Times Cited: 9
Sea Buckthorn Polysaccharide Ameliorates Colitis
Qinqin Ouyang, Xin Li, Yongheng Liang, et al.
Nutrients (2024) Vol. 16, Iss. 9, pp. 1280-1280
Open Access | Times Cited: 9
Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
Yaru Qiao, Xiaohua Tang, Ziyue Liu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 607-607
Open Access | Times Cited: 8
Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens
Mihály Koncz, Tamás Stirling, Hiba Hadj Mehdi, et al.
Cell (2024)
Open Access | Times Cited: 8
Correlation between the structures of natural polysaccharides and their properties in regulating gut microbiota: Current understanding and beyond
Wing-Shan Keung, Wei-Hao Zhang, Han-Yan Luo, et al.
Carbohydrate Polymers (2025) Vol. 352, pp. 123209-123209
Closed Access | Times Cited: 1
Isolation and characterization of a novel lytic phage K14-2 infecting diverse species of the genus Klebsiella and Raoultella
Seomin Kang, Jeong-Eun Han, Yun-Hee Choi, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 1
A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules
Moamen M. Elmassry, Kohei Sugihara, Pranatchareeya Chankhamjon, et al.
Cell Host & Microbe (2025) Vol. 33, Iss. 2, pp. 218-234.e12
Open Access | Times Cited: 1
Advances in Engineered Phages for Disease Treatment
Xiaolin Hou, Zhai Lin, Laiying Fu, et al.
Small Methods (2025)
Closed Access | Times Cited: 1
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference
Loris Riccardo Lopetuso, S Deleu, Pierluigi Puca, et al.
Inflammatory Bowel Diseases (2025)
Closed Access | Times Cited: 1
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Iliyan D. Iliev, Ashwin N. Ananthakrishnan, Chun‐Jun Guo
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 1
Smoking-induced microbial dysbiosis in health and disease
Hagit Shapiro, Kim Goldenberg, Karina Ratiner, et al.
Clinical Science (2022) Vol. 136, Iss. 18, pp. 1371-1387
Open Access | Times Cited: 36
Microbiome-phage interactions in inflammatory bowel disease
Sara Federici, Denise Kviatcovsky, Rafael Valdés‐Mas, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 6, pp. 682-688
Open Access | Times Cited: 33
The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
Stephen Chijioke Emencheta, Chinasa Valerie Olovo, Osita C. Eze, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2416-2416
Open Access | Times Cited: 19
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 19

Scroll to top